loader
Please Wait
Applying Filters...

EUROAPI EUROAPI

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Looking for Poly DL Lactide? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

    SPI Pharma has been solving formulation challenges using superior functional materials.
    Nippon provides high-performance, high-value-added cosmetic, pharmaceutical, and industrial raw materials.
    Previous
    Next
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Nomisma Healthcare (1)

    filter

    01 India (1)

    Close
    4
    refresh Reset Filter
    refreshReset Filter
    Learn More #LearnMore
    price-trend Ask Us

    Nomisma Healthcare

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      PDLLA

      PDF Supplier PDF
      URL Supplier Web Content
      LM Application #LearnMore

      Applications:

      PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

      Ingredient(s): Poly DL Lactide

      Dosage Form: Tablet

      Category: Controlled & Modified Release

      Route of Administration (Grade): Oral, Parenteral
      Pharmacopoeia Reference: NA

      Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Post Enquiry
      POST ENQUIRY